EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benefits versus drawbacks of delaying surgery due to additional consultations in older patients with breast cancer

Brian L Egleston iD, Richard J Bleicher iD, Carolyn Y Fang iD, Thomas J Galloway iD, Slobodan Vucetic iD

Cancer Reports · 2023

DOI: 10.1002/cnr2.1805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2023. Verfasst von Brian L Egleston und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Temple University Health System, 333 Cottman Avenue, Philadelphia, Pennsylvania, …. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Additional evaluations, including second opinions, before breast cancer surgery may improve care, but may cause detrimental treatment delays that could allow disease progression.

Aims

We investigate the timing of surgical delays that are associated with survival benefits conferred by preoperative encounters versus the timing that are associated with potential harm. Methods and results We investigated survival outcomes of SEER Medicare patients with stage 1–3 breast cancer using propensity score‐based weighting. We examined interactions between the number of preoperative evaluation components and time from biopsy to definitive surgery. Components include new patient visits, unique surgeons, medical oncologists, or radiation oncologists consulted, established patient encounters, biopsies, and imaging studies. We identified 116 050 cases of whom 99% were female and had an average age of 75.0 ( SD = 6.2). We found that new patient visits have a protective association with respect to breast cancer mortality if they occur quickly after diagnosis with breast cancer mortality subdistribution Hazard Ratios [sHRs] = 0.87 (95% Confidence Interval [CI] 0.76–1.00) for 2, 0.71 (CI 0.55–0.92) for 3, and 0.63 (CI 0.37–1.07) for 4+ visits at minimal delay. New patient visits predict worsened mortality compared with no visits if the surgical delay is greater than 33 days (CI 14–53) for 2, 33 days (CI 17–49) for 3, and 44 days (CI 12–75) for 4+. Medical oncologist visits predict worse outcomes if the surgical delay is greater than 29 days (CI 20–39) for 1 and 38 days (CI 12–65) for 2+ visits. Similarly, surgeon encounters switch from a positive to a negative association if the surgical delay exceeds 29 days (CI 17–41) for 1 visit, but the positive estimate persists over time for 3+ surgeon visits.

Conclusion

Preoperative visits that cause substantial delays may be associated with increased mortality in older patients with breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleAgedUnited StatesMedicareReferral and ConsultationMastectomyProportional Hazards Models

Stichwörter der Autor:innen

SEER-Medicarebreast cancersurgical delayssurvival

Autor:innen und Institutionen

  • Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Temple University Health System, 333 Cottman Avenue, Philadelphia, Pennsylvania, 19111, USA.
  • Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, 333 Cottman Avenue, Philadelphia, Pennsylvania, 19111, USA.
  • Cancer Prevention and Control Program, Fox Chase Cancer Center, Temple University Health System, 333 Cottman Avenue, Philadelphia, Pennsylvania, 19111, USA.
  • Department of Radiation Oncology, Fox Chase Cancer Center, Temple University Health System, 333 Cottman Avenue, Philadelphia, Pennsylvania, 19111, USA.
  • Department of Computer and Information Sciences, Temple University, 1925 N. 12th St., 314 SERC, Philadelphia, Pennsylvania, 19122, USA.

ORCID-Profile: Brian L Egleston, Richard J Bleicher, Carolyn Y Fang, Thomas J Galloway, Slobodan Vucetic

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Egleston, B. L., Bleicher, R. J., Fang, C. Y., Galloway, T. J., & Vucetic, S. (2023). Benefits versus drawbacks of delaying surgery due to additional consultations in older patients with breast cancer. Cancer Reports. https://doi.org/10.1002/cnr2.1805

Vancouver

Egleston BL, Bleicher RJ, Fang CY, Galloway TJ, Vucetic S. Benefits versus drawbacks of delaying surgery due to additional consultations in older patients with breast cancer. Cancer Reports. 2023. doi:10.1002/cnr2.1805

BibTeX
@article{Egleston2023,
  author = {Egleston, Brian L and Bleicher, Richard J and Fang, Carolyn Y and Galloway, Thomas J and Vucetic, Slobodan},
  title = {Benefits versus drawbacks of delaying surgery due to additional consultations in older patients with breast cancer},
  journal = {Cancer Reports},
  year = {2023},
  doi = {10.1002/cnr2.1805}
}
Kostenlos starten →